{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:24:55Z","timestamp":1795011895346,"version":"4.9.1"},"reference-count":37,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2022,1,11]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>Mortality from chronic liver disease (CLD) in the UK has increased by over 400% since 1970, driven by alcohol, non-alcoholic fatty liver disease and hepatitis C virus, the natural histories of which can all be improved by early intervention. Patients often present with advanced disease, which would be preventable if diagnosed earlier and lifestyle change opportunities offered.<\/jats:p>\n               <jats:p>Liver function tests (LFTs) are very commonly measured. Approximately 20% are abnormal, yet the majority are not investigated according to guidelines. However, investigating all abnormal LFTs to identify early liver disease would overwhelm services. Recently, several diagnostic pathways have been implemented across the country; some focus on abnormal LFTs and some on stratifying at-risk populations.<\/jats:p>\n               <jats:p>This review will collate the evidence on the size of the problem and the challenges it poses. We will discuss the limitations and restrictions within systems that limit the responses available, review the current pathways being evaluated and piloted in the UK, and explore the arguments for and against LFT-based approaches and \u2018case-finding strategies\u2019 in the community diagnosis of liver disease. Furthermore, the role of fibrosis assessment methods (including scoring systems such as Fibrosis-4 (FIB-4) index, the enhanced liver fibrosis test and elastography) within these pathways will also be discussed.<\/jats:p>\n               <jats:p>In conclusion, this review aims to establish some principles which, if adopted, are likely to improve the diagnosis of advanced liver disease, and identify the areas of contention for further research, in order to establish the most effective community detection models of liver disease.<\/jats:p>","DOI":"10.1136\/flgastro-2021-101833","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T13:25:39Z","timestamp":1643030739000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Identification of liver disease: why and how"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-2073","authenticated-orcid":false,"given":"Iain","family":"Macpherson","sequence":"first","affiliation":[{"name":"Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK"},{"name":"Department of Gastroenterology and Hepatology, Ninewells Hospital and Medical School, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushala W M","family":"Abeysekera","sequence":"additional","affiliation":[{"name":"Department of Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Harris","sequence":"additional","affiliation":[{"name":"NIHR Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS Trust, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Mansour","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Gateshead Health NHS Foundation Trust, Gateshead, UK"},{"name":"Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5638-2453","authenticated-orcid":false,"given":"Stuart","family":"McPherson","sequence":"additional","affiliation":[{"name":"Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Liver Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Rowe","sequence":"additional","affiliation":[{"name":"Leeds Institute for Medical Research, University of Leeds, Leeds, UK"},{"name":"Leeds Liver Unit, St James's University Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Institute for Liver and Digestive Health, University College London Division of Medicine, London, UK"},{"name":"Sheila Sherlock Liver Centre, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2164-4476","authenticated-orcid":false,"given":"John F","family":"Dillon","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK"},{"name":"Department of Gastroenterology and Hepatology, Ninewells Hospital and Medical School, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0739-3332","authenticated-orcid":false,"given":"Andrew","family":"Yeoman","sequence":"additional","affiliation":[{"name":"Gwent Liver Unit, Aneurin Bevan University Health Board, Newport, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"2025090708400661000_13.5.367.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61838-9"},{"key":"2025090708400661000_13.5.367.2","unstructured":"British Liver Trust . The alarming impact of liver disease in the UK: facts and statistics. United Kingdom, 2019."},{"key":"2025090708400661000_13.5.367.3","unstructured":"Cancer research UK. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/mortality#heading-Four"},{"key":"2025090708400661000_13.5.367.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100232","article-title":"Primary liver cancer in the UK: incidence, incidence-based mortality, and survival by subtype, sex, and nation","volume":"3","author":"Burton","year":"2021","journal-title":"JHEP Rep"},{"key":"2025090708400661000_13.5.367.5","unstructured":"Public Health England . Liver disease profiles: short statistical commentary, 2018."},{"key":"2025090708400661000_13.5.367.6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S2468-1253(16)30205-9","article-title":"Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review","volume":"2","author":"Harris","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090708400661000_13.5.367.7","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2019-0250"},{"key":"2025090708400661000_13.5.367.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162980","article-title":"The Scottish alcoholic liver disease evaluation: a population-level matched cohort study of hospital-based costs, 1991-2011","volume":"11","author":"Bouttell","year":"2016","journal-title":"PLoS One"},{"key":"2025090708400661000_13.5.367.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60892-8"},{"key":"2025090708400661000_13.5.367.10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/alcalc\/agaa143","article-title":"Does advice based on biomarkers of liver injury or non-invasive tests of liver fibrosis impact high-risk drinking behaviour: a systematic review with meta-analysis","volume":"56","author":"Subhani","year":"2021","journal-title":"Alcohol Alcohol"},{"key":"2025090708400661000_13.5.367.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.04.034"},{"key":"2025090708400661000_13.5.367.12","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2018-101155"},{"key":"2025090708400661000_13.5.367.13","article-title":"PO337: funded referral to a commercial weight loss provider is effective in achieving weight loss in non-alcoholic fatty liver disease","volume":"75","author":"I RS","year":"2021","journal-title":"J Hepatol"},{"key":"2025090708400661000_13.5.367.14","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2020-101669"},{"key":"2025090708400661000_13.5.367.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32908-3"},{"key":"2025090708400661000_13.5.367.16","doi-asserted-by":"crossref","unstructured":"Donnan PT , McLernon D , Dillon JF , et al . Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE). Health Technol Assess 2009;13.doi:10.3310\/hta13250","DOI":"10.3310\/hta13250"},{"key":"2025090708400661000_13.5.367.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.03.020"},{"key":"2025090708400661000_13.5.367.18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314924"},{"key":"2025090708400661000_13.5.367.19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496"},{"key":"2025090708400661000_13.5.367.20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"2025090708400661000_13.5.367.21","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.216077"},{"key":"2025090708400661000_13.5.367.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051906"},{"key":"2025090708400661000_13.5.367.23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jhep.2019.05.033","article-title":"Intelligent liver function testing (iLFT): a trial of automated diagnosis and staging of liver disease in primary care","volume":"71","author":"Dillon","year":"2019","journal-title":"J Hepatol"},{"key":"2025090708400661000_13.5.367.24","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(20)30595-X","article-title":"Introduction of \u201creflex\u201d AST testing in primary care increases detection of advanced liver disease: the Gwent AST project (GAP)","volume":"73","author":"Yeoman","year":"2020","journal-title":"J Hepatol"},{"key":"2025090708400661000_13.5.367.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.033"},{"key":"2025090708400661000_13.5.367.26","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2019-101177"},{"key":"2025090708400661000_13.5.367.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015659"},{"key":"2025090708400661000_13.5.367.28","doi-asserted-by":"crossref","first-page":"100293","DOI":"10.1016\/j.jhepr.2021.100293","article-title":"Embedding assessment of liver fibrosis into routine diabetic review in primary care","volume":"3","author":"Mansour","year":"2021","journal-title":"JHEP Rep"},{"key":"2025090708400661000_13.5.367.29","first-page":"S191","article-title":"PO-1125 using the enhanced liver fibrosis test in primary care: a practical pathway to priotise patients with fibrosis in fatty liver disease","volume":"75","author":"Hinkson","year":"2021","journal-title":"J Hepatol"},{"key":"2025090708400661000_13.5.367.30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.medcli.2019.01.030","article-title":"Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care","volume":"153","author":"Caballeria","year":"2019","journal-title":"Med Clin"},{"key":"2025090708400661000_13.5.367.31","unstructured":"Yki-J\u00e4rvinen HAP , Eskelinen S , et al . Non-alcoholic fatty liver disease (NAFLD), 2020."},{"key":"2025090708400661000_13.5.367.32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"2025090708400661000_13.5.367.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.12.048"},{"key":"2025090708400661000_13.5.367.34","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2019-101304"},{"key":"2025090708400661000_13.5.367.35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37 Suppl 1","author":"Bellentani","year":"2017","journal-title":"Liver Int"},{"key":"2025090708400661000_13.5.367.36","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","article-title":"Cirrhosis and its complications: evidence based treatment","volume":"20","author":"Nusrat","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025090708400661000_13.5.367.37","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1016\/S2468-2667(21)00052-9","article-title":"Impact of minimum unit pricing on alcohol purchases in Scotland and Wales: controlled interrupted time series analyses","volume":"6","author":"Anderson","year":"2021","journal-title":"Lancet Public Health"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2021-101833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:40:15Z","timestamp":1757259615000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2021-101833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,8,5]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/flgastro-2021-101833"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2021-101833","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]}}}